Biodesix, Inc. BDSX Increase (decrease) in contract liabilities and current deferred income
Increase (decrease) in contract liabilities and current deferred income at other companies
Other financials
Where this comes from
Reported directly by Biodesix, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInContractWithCustomerLiability.
The official record: Biodesix, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Biodesix, Inc.'s increase (decrease) in contract liabilities and current deferred income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Biodesix, Inc.'s increase (decrease) in contract liabilities and current deferred income?
- Biodesix, Inc. (BDSX) reported increase (decrease) in contract liabilities and current deferred income of -$766K in Q1 2026.
- How has Biodesix, Inc.'s increase (decrease) in contract liabilities and current deferred income changed year-over-year?
- Biodesix, Inc.'s increase (decrease) in contract liabilities and current deferred income decreased by 1022.9% year-over-year, from $83K to -$766K.
- What is the long-term trend for Biodesix, Inc.'s increase (decrease) in contract liabilities and current deferred income?
- Over 2 years (2021 to 2023), Biodesix, Inc.'s increase (decrease) in contract liabilities and current deferred income has grown at a -34.7% compound annual growth rate (CAGR), from -$1.77M to -$755K.